Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Allergan plc (NYSE:AGN)

248.98
Delayed Data
As of Jul 22
 +1.14 / +0.46%
Today’s Change
195.50
Today|||52-Week Range
340.34
-20.33%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2015
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Revenue and IncomeNet Revenues5.8B4.1B4.2B3.8B
 
 
 
 
 
Cost of Goods Sold2.0B1.2B1.1B751.5M
 
 
 
 
 
Depreciation And Amortization1.7B1.6B1.6B1.6B
 
 
 
 
 
 
Operating ExpensesGross Income2.0B1.3B1.5B1.4B
 
 
 
 
 
General Expenses1.7B2.1B1.5B1.4B
 
 
 
 
 
Research And Development428.6M1.2B391.2M352.2M
 
 
 
 
 
Total Operating Expenses5.5B4.9B4.2B3.8B
 
 
 
 
 
 
Non-Operating ExpensesOperating Income273.5M-769.7M7.5M20.5M
 
 
 
 
 
Extraordinary Credit20.6M----100.0K
 
 
 
Extraordinary Charge-495.2M-578.2M-278.9M-176.1M
 
 
 
 
 
Interest Expense On Debt341.8M340.2M341.3M332.8M
 
 
 
 
 
Other Expenses-8.6M4.6M-264.6M2.2M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-548.9M-1.7B-874.1M-483.0M
 
 
 
 
 
Income Taxes-307.3M-824.9M-105.0M-402.0M
 
 
 
 
 
Minority Interest-1.5M-1.4M-1.6M-700.0K
 
 
 
 
 
Preferred Dividend-69.6M-69.6M-69.6M-69.6M
 
 
 
 
 
Discontinued Operations0.006.2B139.8M337.4M
 
 
 
 
Net Income-243.1M5.3B-630.9M255.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS392.6M393.6M394.2M394.8M
 
 
 
 
 
Shares To Calculate EPS Diluted392.6M393.6M394.2M394.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.80$13.29-$1.78$0.47
 
 
 
 
 
EPS Diluted-$0.80$13.29-$1.78$0.47